Additional file 1: of Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies
Table S1. Pulmonary medication use prior to enrolment (treated set). Table S2. Arithmetic mean, geometric mean and median endurance times after 6 weeks (full analysis set). Table S3. Geometric mean (SE) endurance time after 6 weeks by GOLD (full analysis set). Table S4. Peak expiratory flow outcomes at 6 weeks (full analysis set). Figure S1. Hierarchical testing order: each test was considered confirmatory only if all of the previous tests were positive. Figure S2. Participant flow in (a) Study 1222.37 and (b) Study 1222.38. Figure S3. Exercise endurance time after 6 weeks for (a) Study 1222.37 and (c) Study 1222.38. Log10-transformation of exercise endurance time after 6 weeks for (b) Study 1222.37 and (d) Study 1222.38 (full analysis set). (DOCX 631 kb
